Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes
about
Transsulfuration pathway thiols and methylated arginines: the Hunter Community StudyRegulation of peripheral blood flow in complex regional pain syndrome: clinical implication for symptomatic relief and pain management.Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration.The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.Biomarkers of peripheral arterial disease.Diabetes and alpha lipoic Acid.Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitusPlasma nitric oxide level is correlated with microvascular functions in the peripheral arterial disease.HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammationTissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patientsSupplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage.Role of asymmetric dimethylarginine in cardiovascular disease and diabetes.Red cell distribution width and risk of peripheral artery disease: analysis of National Health and Nutrition Examination Survey 1999-2004.Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.
P2860
Q28485286-49F48E54-B876-4295-83E4-F77A0E451EFAQ33506195-E81CA1BC-0592-4C7D-B458-34E09B995E97Q34134862-85489B43-22F9-43B0-AE7C-B463ACBD8470Q34632841-D7285E3B-5D1B-485F-A6DC-0A3F0E2DAB66Q34670457-9D434FE8-5056-4FC5-971D-254146F2DA66Q35090446-ACD1EEA3-7CCD-4D12-958A-5178122780EBQ35170187-577675C6-0F4F-40B4-B22C-489C2F320C01Q35564911-BBED02F6-A335-4DEF-BF0B-5DC8393174E6Q35622245-5B9F749D-0B0A-4CE8-9CCD-03E4D2046178Q36226551-5693B334-5E34-4EC9-9A45-127AD8E3C4CEQ36327164-F07AAEDD-4504-451F-AA97-63D7D8AA1E4CQ36844696-4F88BF12-C92F-4DEC-BC64-177D42321C5DQ37718775-E29A93AA-6134-487C-81E9-E3C6FBF56ACDQ37728038-7278F805-2E81-47BF-B85D-DF1D6261639BQ37888834-FFFEB238-6FB3-47A0-8E8E-4F1FC960577CQ43061621-16438E93-DE73-4CBB-A7CE-29B71B913747Q43615743-E03D61EF-0BA6-45A3-AE2A-9D8EC27AA3E3Q51158383-7A0BE6FB-82B9-4BDE-A962-952AD1C7AEA5Q51474582-A8E091DC-9F33-44CF-92BC-CA22428890C1
P2860
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@ast
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@en
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@nl
type
label
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@ast
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@en
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@nl
prefLabel
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@ast
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@en
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@nl
P2093
P1433
P1476
Asymmetric dimethylarginine is ...... patients with type 2 diabetes
@en
P2093
Christoph Schnack
Friedrich Mittermayer
Guntram Schernthaner
Katarzyna Krzyzanowska
Martin Hofer
Walter Krugluger
P304
P356
10.1016/J.ATHEROSCLEROSIS.2005.12.007
P407
P577
2006-11-01T00:00:00Z